Stockreport

Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD

AstraZeneca PLC Ordinary Shares  (AZN) 
Last astrazeneca plc ordinary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF Third positive pivotal Phase III clinical trial of AstraZeneca’s IL-33-targeting biologic further demonstrates its benefits in COPD WILMINGTON, Del.--(BUSINESS WIRE)- [Read more]